For example, Durvalumab is a kind of PD-L1 monoclonal antibody belonging to the IgG1 class, which has been approved by the FDA and can be used to treat UC (Urothelial Carcinoma) and NSCLC (Non-Small Cell Lung Carcinoma). Here, CD274 is linked to non-small cell lung carcinoma.